Navigation Links
Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
Date:3/28/2013

MOUNTAIN VIEW, Calif., March 28, 2013 /PRNewswire/ -- Edison Pharmaceuticals today announced that it has entered into a research/development and commercialization agreement with Dainippon Sumitomo Pharma Co., Ltd. (DSP) for the development of EPI-743 and EPI-589 in Japan. Under the terms of the agreement, DSP will gain development and commercialization rights in Japan in exchange for Edison receiving $35 million in upfront and $15 million in R&D support. In addition, Edison will be eligible to receive $10-35 million in development milestones per indication and up to $460M in commercial milestone payments as well as royalties on commercial sales.

The initial scope of the transaction includes both pediatric orphan inherited mitochondrial and adult central nervous system diseases. Under the terms of the agreement, DSP will undertake activities required for development, approval, and commercialization of EPI-743 in Japan. The work will initially focus on orphan pediatric mitochondrial disease. Edison will retain 100% ownership and direct all research, clinical, and commercial development of EPI-743 and EPI-589 outside of Japan.

In addition, the parties will collaborate on the research and development of EPI-589 with a focus on adult central nervous system disease. This collaboration is based upon the emerging body of data implicating redox and mitochondrial dysfunction as a root cause of neurologic disorders.

Edison's translational platform is based on redox biochemistry.  It bridges key learnings derived from genetically confirmed pediatric rare mitochondrial disease to adult central nervous system disorders where redox and mitochondrial dysfunction are likely to also play a cr
'/>"/>

SOURCE Edison Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Edison Pharmaceuticals & Bambino Gesu Childrens Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
2. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
3. Edison Pharmaceuticals Closes $20M Series F Financing
4. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
5. Massive Hiring Event for Life Science Professionals in Edison, NJ on 9/18/12
6. Edison Pharmaceuticals Announces Positive Results of EPI-743 Phase 2A Leigh Syndrome Clinical Trial
7. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
8. Carolinas HealthCare System and Edison Nation Collaborate to Drive Medical Innovation and Technology
9. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
10. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
11. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
(Date:8/28/2015)... 2015  Delays in the launch and execution ... the decision-making process, resulting in missed opportunities and ... biopharmaceutical companies to develop a tactical approach to ... and more meaningful insights. According ... three-quarters of benchmarked study participants use review cycle ...
(Date:8/28/2015)... , Aug. 28, 2015 ... addition of the "Investigation Report on China,s Bevacizumab ... Developed by Roche under the trade name of Avastin, ... world. In Feb.26, 2010, it was approved by CFDA ... in China all come from ...
Breaking Medicine Technology:healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Bevacizumab Market 2015-2019 2
... Technologies, Inc. (the "Company") (Nasdaq: CMED ), ... announced that it has made the payment for all ... 3.5% Convertible Senior Subordinated Notes (the "2011 Notes") which ... 2011 Notes will be cancelled accordingly. None of the ...
... Scripts, Inc. (Nasdaq: ESRX ) announced today ... Delaware corporation (“Aristotle”), has successfully priced a private offering ... amount of 2.750% senior notes due 2014, $1.25 billion ... $1.25 billion aggregate principal amount of 4.750% senior notes ...
Cached Medicine Technology:Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering 2Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering 3Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering 4Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering 5Express Scripts, Inc. Announces Pricing of $4.1 Billion Senior Notes Offering 6
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... Castle ... to the practice. Dr. Pedram Ghasri is a graduate of the University of California, ... and continued his studies at the University of California, Irvine Medical School. As a ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
(Date:8/31/2015)... ... 2015 , ... For 12 years, since 2004, the Mesothelioma Applied Research ... Awareness Day . On this day, and in the weeks leading up to it, ... helping the cause. , “One of the ways a person can be involved is ...
(Date:8/31/2015)... ... ... MeYou Health ®, a social well-being company and wholly owned subsidiary of Healthways, ... in-app step tracker. , Walkadoo is a pedometer-based walking program that provides ... every Walkadoo member 10,000 steps a day (as is typical for many walking programs), ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like coming home. Life-long Fox ... Geneva. During his first days on the job, he’s run into residents of the ... I like knowing that they’re living in such a wonderful place,” he said. GreenFields, ...
Breaking Medicine News(10 mins):Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2
... is no stopping the Chinese. Not a single sphere in ... The next target in its crosshairs is the cooked ... it very glibly, "China is seeking to familiarize the U.S. ... poultry lobby is worried. It talks about such common practices ...
... of those who take herbal supplements, do not check scientific ... herbal medicines to ease specific ailments do so on the ... the credentials of purported claims or seek evidence based results. ... of Iowa viewed extensive data from a 2002 national health ...
... goal for inflation of an angioplasty balloon in a ... is so revered its been codified in clinical guidelines, ... deadline really critical" Two experts will debate that question ... for Cardiovascular Angiography and Interventions (SCAI). ,Allowing ...
... artificial plastic blood, which they claim could act as a ... in war zones. ,The new artificial blood ... atom at their core, like haemoglobin, that can carry oxygen ... looking for extra funding to develop a final prototype that ...
... an outbreak of mumps beginning in Nova Scotia and now ... are the most affected. ,The latest outbreak of ... in Nova Scotia has put health officials in top alert. ... to administer a booster shot, as the latest attacks prove ...
... at Chicago explain in the May 11 issue of Circulation ... to slow the rapid beating of the heart's "fight-or-flight" reaction ... right chamber is responsible for setting the pace of the ... human heart, one cell - the pacemaker cell - beats ...
Cached Medicine News:Health News:China Eyeing US Cooked Chickens Market 2Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Debate Focuses on Door-to-balloon Time in Heart Attack Treatment 2Health News:Mumps Breaks Out In Canada 2Health News:Slowing the Racing Heart 2
... were designed for ease of use, and ... blood sample is collected. The wider-diameter BD ... an integrated collection scoop and improved mixing ... is available for hematology and chemistry applications, ...
... The Identity pacemaker family, which includes ... clinicians with the most advanced pacemaker ... Suppression algorithm, the first and only ... suppress atrial fibrillation (AF). The AF ...
... The Identity pacemaker family, which includes ... clinicians with the most advanced pacemaker ... Suppression algorithm, the first and only ... suppress atrial fibrillation (AF). The AF ...
... Identity pacemaker family, which includes the ... with the most advanced pacemaker technology ... algorithm, the first and only U.S. ... atrial fibrillation (AF). The AF Suppression ...
Medicine Products: